Piramal Pharma Limited has informed the Exchange regarding resignation of Ms. Tanya Sanish as Company Secretary & Compliance Officer of the Company w.e.f. February 20, 2026.
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Smallcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Piramal Pharma Limited has informed the stock exchange that Ms. Tanya Sanish has resigned as the Company Secretary & Compliance Officer of the company. Her resignation will take effect from February 20, 2026. The Company Secretary is a Key Managerial Personnel (KMP) under Indian company law and is responsible for regulatory compliance, board support, and shareholder communications. No reason for the resignation has been disclosed in the filing. The company will now need to appoint a replacement within the stipulated regulatory timeline to avoid compliance gaps.
This is a mid-level KMP exit and is generally seen as a routine leadership change. It is unlikely to materially affect stock price, though investors should watch for a timely replacement appointment to ensure no disruption to compliance and corporate governance.